GlassScriptPhysician profile
Deray Williams
NPI 1073067856
$5,900.02
in general payments reported to CMS, 2019-2025
40 companies · $2,075 in 2025
The $2,075 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $289 · 2023: $753 · 2024: $2,535 · 2025: $2,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,209 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,209.01 |
| Education | $154.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.74 | 2021-2025 | |
| Amgen INC. | $396.22 | 2023-2025 | Repatha, Evenity, Otezla |
| Axsome Therapeutics, INC. | $330.60 | 2024-2025 | Auvelity, Sunosi, Symbravo |
| Astrazeneca Pharmaceuticals LP | $320.77 | 2024-2025 | Breztri, Airsupra |
| Phathom Pharmaceuticals, INC. | $312.74 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $285.87 | 2024-2025 | Rexulti |
| Novo Nordisk INC | $278.27 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $276.04 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $255.88 | 2021-2024 | Ajovy, Austedo Xr |
| Gilead Sciences, INC. | $232.64 | 2025 | Yeztugo |
| Bayer Healthcare Pharmaceuticals INC. | $165.51 | 2025 | |
| Dexcom, INC. | $157.27 | 2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Astellas Pharma US INC | $154.00 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $145.81 | 2025 | Purified Cortrophin Gel |
| Radius Health, INC. | $143.81 | 2024-2025 | Tymlos |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deray Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.